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PD-L1 Expression in EBUS-Guided Cytology Specimens of Non-Small Cell Lung Cancer is Not Affected 
by Type of Fixation: A Study of Matched Pairs 
 
Background: No previous trials of immune modulators (IMs) to treat non-small cell lung cancer 
(NSCLC) have included ‘cytology’ specimens, dispersed cells aspirated from a tumour deposit or body 
cavity, for immunochemical assessment of PD-L1, a useful complementary or compulsory companion 
diagnostic test. This has led to the widely-held view that, in the absence of such ‘validation’, cytology 
specimens cannot be used to assess it. In many centres, endobronchial ultrasound (EBUS)-guided 
aspiration of the tumour or intra-thoracic lymph nodes is the preferred means of diagnosis and 
staging of NSCLC and such specimens account for the majority received for analysis. Failure to 
asses them has serious implications for appropriate management and might deny patients effective 
therapy. Much of this reluctance centres on the alleged effect of fixation in alcohol-based fixatives, 
the preferred method of cytopathologists, rather than formalin, the standard fixation medium for 
tissue specimens, on the expression of PD-L1 on the cell surface. 
 
Method: We compared expression of PD-L1 in 50 paired specimens of NSCLC, one fixed in an 
alcohol-based fixative and one in neutral-buffered formalin, taken from the same tumour deposit or 
lymph node during the same procedure. All were spun down and formed into a cell block before 
assessment for PD-L1 expression, which was by two appropriately-trained pathologists with 
extensive experience in its interpretation. 
 
Result: In none of the 50 pairs studied was there any significant difference, qualitative or 
quantitative, in the pattern or extent of PD-L1 expression and, in the great majority, it was 
identical irrespective of fixation. 
 
Conclusion: There is no evidence from this study that the use of alcohol-based fixatives has any 
effect on the expression of PD-L1 or its interpretation. Notwithstanding the general challenges in 
accurately assessing such expression, which are common to specimens of tissue as well as dispersed 
cells, pathologists should feel able to interpret cytology specimens with confidence and clinicians 
able to rely on the results. 
